Fatigue lasting up to a year is common after a transient ischemic attack, especially in individuals with prior anxiety or ...

Longitudinal Changes in Airway Mucus Plugs and FEV1 in COPD - (https://www.nejm.org/doi/10.1056/NEJMc2502456) ...

Patients with lower physical function before starting daratumumab therapy showed greater treatment benefit than those who ...

("ArkBio") today announced positive top-line Phase II study results for its novel anti-fibrotic drug AK3280 in treatment of idiopathic pulmonary fibrosis (IPF). The study, led by Professor Huaping Dai ...

On May 15, 2025 , the latest announcement released by the National Medical Products Administration attracted widespread attention in the oncology community and the pharmaceutical market.

Eosinophilic esophagitis (EoE) is a multifaceted disease marked by diverse clinical features, including variations in age of onset, symptom ...

FDA clearance for P-Cure now includes full-body indications and supine treatment positions, significantly expanding clinical versatility and patient access SHILAT, Israel, May 15, 2025 ...

Landmark Study from CHOP and Penn Medicine Showcases the Power of Customized Gene Editing Therapy to Treat Patient with Rare Metabolic Disease PHILADELPHIA and NEW ORLEANS, May 15, 2025 /PRNewswire/ - ...

Improve your health during travel with 9 practical tips based on expert advice. Learn how good nutrition can assist you in ...

SparX Biopharmaceutical Corp ("SparX"), a clinical-stage biotechnology company pioneering next-generation antibody-drug conjugate (ADC) technologies, today announced the signing of a research ...

BiaCure Therapies, an emerging innovator in non-invasive medical technology, today announced it has been awarded a Small Business Innovation Research (SBIR) Phase I grant from the National Institutes ...

Some women may be unaware they're living with risks for heart disease, kidney disease and metabolic conditions like diabetes, which drive risk for cardiovascular disease. Cardiovascular Disease is the ...